BioTech Companies to Watch: Overcoming Macro Challenges

This is an opportune moment for leading pharmaceutical and life sciences companies to embark on bold transformations for their businesses. Amidst challenges such as inflation, talent shortages, and escalating capital costs, the discussion will also explore the additional headwinds arising from blockbuster patent expiries, intensifying competition, and the implications of the Inflation Reduction Act (IRA) of 2022. ----------------------------------------------------------------------------------------------------------------------------------------------------------- Guest: Michael Yurkowsky, CEO - H-CYTE https://ir.hcyte.com/ Host: Tony Noto, Editor - Benzinga https://www.benzinga.com ----------------------------------------------------------------------------------------------------------------------------------------------------------- SUBSCRIBE ✔ 🎥https://www.youtube.com/benzinga BENZINGA PRO TOOLS: 📈pro.benzinga.com ✅Free 2 week trial, no credit card required✅ 🙌Use coupon code YOUTUBE20 to get 20% off🙌 WEBSITE & SOCIALS: 💻 Website: https://www.benzinga.com 👍Benzinga on Instagram & Facebook @ Benzinga 🛎Benzinga on TikTok & Twitter @ Benzinga MAKE MONEY, BECOME A BENZINGA AFFILIATE: ♻️Earn 30% commission on new subscriptions♻️ 💰https://benzinga.partnerstack.com/💰 PODCASTS: 🔈 https://www.benzinga.com/podcasts 🔈 BENZINGA’s CORE BUSINESSES: ✅Financial news articles: http://benzinga.com ✅Real-time news headlines: http://pro.benzinga.com ✅Financial, Market, and Alternative data APIs: http://cloud.benzinga.com ✅The Benzinga Global Fintech Awards: http://benzingafintechawards.com Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, futures, and crypto is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions. #Benzinga #BioTech